Altogether, the observations that Col15A1 expression level is abnormally elevated in DCM‐developing DM1 patients and that attenuation of its Drosophila ortholog Mp could ameliorate the DCM phenotype suggest that Col15A1 could be a novel therapeutic target in DM1. The gene discussed is PPP1CB; the disease is myotonic dystrophy type 1.